Cerebain Biotech

Cerebain Biotech, established in 2007 and based in Costa Mesa, California, is a biomedical company specializing in the development of treatments for Alzheimer's disease. Its primary focus is the creation and clinical development of a minimally invasive, implantable medical device that leverages the regenerative properties of the omentum, a layer of tissue that generates biological agents nourishing nerves and promoting growth. Additionally, Cerebain Biotech explores synthetic drug solutions to complement its medical device offerings.

Wesley Tate

CFO

1 past transactions

Diabetes Reversal Group

Corporate Round in 2022
The Diabetes Reversal Group's goal is to help people with metabolic imbalances by offering a drug-free, all-natural approach to treating diabetes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.